They have sway in the marketplace as well as very good PR . Great way to showcase any company. If you don't subscribe I recommend it. Great to trade off if not in for the long run .
- Forums
- ASX - By Stock
- NTI
- Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint
NTI
neurotech international limited
Add to My Watchlist
0.00%
!
1.8¢

Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $3.02K | 167.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35000 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 324439 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35000 | 0.018 |
4 | 999081 | 0.017 |
7 | 764000 | 0.016 |
6 | 1456079 | 0.015 |
4 | 1219063 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 324439 | 3 |
0.020 | 649998 | 2 |
0.021 | 167015 | 1 |
0.022 | 237000 | 3 |
0.023 | 12000 | 1 |
Last trade - 12.10pm 15/07/2025 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online